{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:15:59Z","timestamp":1795043759552,"version":"4.10.2"},"reference-count":48,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014408","name":"National Institute of Geriatrics, Rheumatology and Rehabilitation","doi-asserted-by":"publisher","award":["Core Grant S18"],"award-info":[{"award-number":["Core Grant S18"]}],"id":[{"id":"10.13039\/501100014408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre, Poland","doi-asserted-by":"publisher","award":["2018\/30\/E\/NZ5\/00104 and 2015\/17\/D\/NZ5\/02219."],"award-info":[{"award-number":["2018\/30\/E\/NZ5\/00104 and 2015\/17\/D\/NZ5\/02219."]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>This study aimed to investigate the associations of microRNA (miRs) signatures with cytokines, serum lipids, and disease activity in patients with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and rheumatoid arthritis (RA). In total, 65 patients (PsA n = 25, AS n = 25, RA n = 15) and 25 healthy controls (HC) were enrolled into the study. The expression of miR-223-5p, miR-92b-3p, miR-485-3p, miR-10b-5p, let-7d-5p, miR-26a-2-3p, miR-146b-3p, and cytokines levels were measured in sera. DIANA-mirPath analysis was used to predict pathways targeted by the dysregulated miRs. Disease activity scores were calculated. Lipid profile, uric acid, glucose level, and C-reactive protein (CRP) concentrations were determined in the blood. Based on lipid profiles, the PsA group had hypertriglyceridaemia, and RA patients revealed mixed dyslipidaemia, while in AS, no specific changes were found. miR expression analysis revealed upregulation of miR-26a-2-3p and miR-10b-5p in PsA, miR-485-3p in AS, and let-7d-5p in RA. Several correlations between disease activity indexes, metabolites levels, and expression of miRs were observed in PsA, RA, and AS patients. Finally, in ROC analysis, miR-26a-2-3p\/miR-485-3p, and let-7d-5p\/miR-146b-3p tandems revealed high sensitivity and specificity in distinguishing between PsA, AS, and RA. Our study illustrates the superiority of miR expressions in distinguishing between RA, PsA, and AS. In PsA, a unique regulatory pathway exists through miR-26a-2-3p, miR-223-5p, miR-10b-5p, and miR-92b-3p that converges proatherogenic metabolism and disease activity.<\/jats:p>","DOI":"10.3390\/biomedicines10040893","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T21:33:42Z","timestamp":1649885622000},"page":"893","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-4063","authenticated-orcid":false,"given":"Krzysztof","family":"Bonek","sequence":"first","affiliation":[{"name":"Department of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9068-3885","authenticated-orcid":false,"given":"Ewa","family":"Kuca Warnawin","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kornatka","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Pleba\u0144czyk","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Burakowski","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W\u0142odzimierz","family":"Ma\u015bli\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Wis\u0142owska","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5717-4472","authenticated-orcid":false,"given":"Piotr","family":"G\u0142uszko","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0961-6130","authenticated-orcid":false,"given":"Marzena","family":"Ciechomska","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"ref_1","first-page":"S43","article-title":"A systematic comparison of rheumatoid arthritis and ankylosing spondylitis","volume":"27","author":"Lems","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar4555","article-title":"Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics","volume":"16","author":"Dennis","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"Ramiro","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/ard.2010.142299","article-title":"Diagnostic performance of the ACR\/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH)","volume":"70","author":"Alves","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5114\/reum.2016.61214","article-title":"Cardiovascular risk assessment in rheumatoid arthritis\u2014Controversies and the new approach","volume":"54","author":"Bonek","year":"2016","journal-title":"Reumatologia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.semarthrit.2018.03.005","article-title":"Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis","volume":"48","author":"Cooksey","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13075-017-1281-5","article-title":"The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study","volume":"19","author":"Bakker","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/rheumatology\/kex340","article-title":"The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia","volume":"56","author":"Verheul","year":"2017","journal-title":"Rheumatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/imj.14463","article-title":"Repeat serological testing for anti-citrullinated peptide antibody after commencement of therapy is not helpful in patients with seronegative rheumatoid arthritis","volume":"50","author":"Reid","year":"2020","journal-title":"Intern. Med. J."},{"key":"ref_10","first-page":"304","article-title":"Bone erosions in rheumatoid arthritis: Recent developments in pathogenesis and therapeutic implications","volume":"18","author":"Panagopoulos","year":"2018","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00005-018-0513-y","article-title":"Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-alpha Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients","volume":"66","author":"Ciechomska","year":"2018","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00296-020-04616-2","article-title":"The lipid paradox in rheumatoid arthritis: The dark horse of the augmented cardiovascular risk","volume":"40","author":"Venetsanopoulou","year":"2020","journal-title":"Rheumatol. Int."},{"key":"ref_13","first-page":"3096","article-title":"IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications","volume":"10","author":"Boehncke","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3899\/jrheum.110845","article-title":"The ClASsification for Psoriatic ARthritis (CASPAR) criteria\u2014A retrospective feasibility, sensitivity, and specificity study","volume":"39","author":"Tillett","year":"2012","journal-title":"J. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51","author":"Kay","year":"2012","journal-title":"Rheumatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/annrheumdis-2012-202779","article-title":"EULAR definition of erosive disease in light of the 2010 ACR\/EULAR rheumatoid arthritis classification criteria","volume":"72","author":"Aletaha","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_17","first-page":"ii49","article-title":"Psoriatic arthritis assessment tools in clinical trials","volume":"64","author":"Mease","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kuca-Warnawin, E., Skalska, U., Janicka, I., Musialowicz, U., Bonek, K., Gluszko, P., Szcz\u0119sny, P., Olesi\u0144ska, M., and Kontny, E. (2019). The Phenotype and Secretory Activity of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Patients with Rheumatic Diseases. Cells, 8.","DOI":"10.3390\/cells8121659"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10067-021-05945-8","article-title":"Metabolic syndrome and its effect on the outcomes of rheumatoid arthritis in a multi-ethnic cohort in Singapore","volume":"41","author":"Hee","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1093\/rheumatology\/keab407","article-title":"Comprehensive microRNA and transcriptomic profiling of rheumatoid arthritis monocytes: Role of microRNA-146b in pro-inflammatory progression","volume":"60","author":"Ciechomska","year":"2021","journal-title":"Rheumatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00005-016-0443-5","article-title":"Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis","volume":"64","author":"Wysoczanska","year":"2016","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/eci.12776","article-title":"The role of microRNA-5196 in the pathogenesis of systemic sclerosis","volume":"47","author":"Ciechomska","year":"2017","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8192187","DOI":"10.1155\/2020\/8192187","article-title":"miRNA-10a-5p Alleviates Insulin Resistance and Maintains Diurnal Patterns of Triglycerides and Gut Microbiota in High-Fat Diet-Fed Mice","volume":"2020","author":"Guo","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1440-1746.2009.05949.x","article-title":"Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD","volume":"25","author":"Zheng","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7305380","DOI":"10.1155\/2018\/7305380","article-title":"MicroRNA Expression Profiling in Psoriatic Arthritis","volume":"2018","author":"Pelosi","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11926-021-01027-5","article-title":"MicroRNAs in Axial Spondylarthritis: An Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis","volume":"23","author":"Motta","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"300060520929615","DOI":"10.1177\/0300060520929615","article-title":"MiR-26a inhibits the inflammatory response of microglia by targeting HMGA2 in intracerebral hemorrhage","volume":"48","author":"Jin","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.febslet.2012.03.068","article-title":"MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7","volume":"586","author":"Sun","year":"2012","journal-title":"FEBS Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13578-018-0203-9","article-title":"miR-26a inhibits atherosclerosis progression by targeting TRPC3","volume":"8","author":"Feng","year":"2018","journal-title":"Cell Biosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/eji.201948428","article-title":"Global miRNA and mRNA expression profiles identify miRNA-26a-2-3p-dependent repression of IFN signature in systemic sclerosis human monocytes","volume":"50","author":"Ciechomska","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/jnc.13364","article-title":"microRNA-26a modulates inflammatory response induced by toll-like receptor 4 stimulation in microglia","volume":"135","author":"Kumar","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"701789","DOI":"10.3389\/fmed.2021.701789","article-title":"MicroRNAs as Biomarkers for the Diagnosis of Ankylosing Spondylitis: A Systematic Review and Meta-Analysis","volume":"8","author":"Li","year":"2021","journal-title":"Front. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"943659","DOI":"10.1155\/2015\/943659","article-title":"MicroRNA-223 Expression is Upregulated in Insulin Resistant Human Adipose Tissue","volume":"2015","author":"Chuang","year":"2015","journal-title":"J. Diabetes Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.7150\/ijbs.59876","article-title":"miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation","volume":"17","author":"Jiao","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","article-title":"MicroRNA Regulation of Atherosclerosis","volume":"118","author":"Feinberg","year":"2016","journal-title":"Circ. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11695-019-04104-y","article-title":"Elevated Levels of Circulating miR-92a Are Associated with Impaired Glucose Homeostasis in Patients with Obesity and Correlate with Metabolic Status After Bariatric Surgery","volume":"30","author":"Cereijo","year":"2020","journal-title":"Obes. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1253\/circj.CJ-15-0283","article-title":"High concentrations of uric acid inhibit angiogenesis via regulation of the Kruppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a","volume":"79","author":"Yu","year":"2015","journal-title":"Circ. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbrc.2019.11.020","article-title":"miR-485 suppresses inflammation and proliferation of mesangial cells in an in vitro model of diabetic nephropathy by targeting NOX5","volume":"521","author":"Wu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fmed.2018.00246","article-title":"Classification and Outcome Measures for Psoriatic Arthritis","volume":"5","author":"Leung","year":"2018","journal-title":"Front. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/bjd.12381","article-title":"Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-alpha therapy","volume":"169","author":"Pivarcsi","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"633201","DOI":"10.3389\/fimmu.2021.633201","article-title":"Serum miRNA Signature in Rheumatoid Arthritis and \u201cAt-Risk Individuals\u201d","volume":"12","author":"Cunningham","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"662047","DOI":"10.3389\/fmolb.2021.662047","article-title":"The Molecular Pathophysiology of Psoriatic Arthritis-The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome","volume":"8","author":"Carvalho","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3899\/jrheum.190602","article-title":"Serum MicroRNA Signature as a Diagnostic and Therapeutic Marker in Patients with Psoriatic Arthritis","volume":"47","author":"Wade","year":"2020","journal-title":"J. Rheumatol."},{"key":"ref_44","first-page":"234","article-title":"Anti-CCP: A truly helpful rheumatoid arthritis test?","volume":"62","author":"Braschi","year":"2016","journal-title":"Can. Fam. Physician"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Cannataro, R., Caroleo, M.C., Fazio, A., La Torre, C., Plastina, P., Gallelli, L., Lauria, G., and Cione, E. (2019). Ketogenic Diet and microRNAs Linked to Antioxidant Biochemical Homeostasis. Antioxidants, 8.","DOI":"10.3390\/antiox8080269"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/2211536608666181126093903","article-title":"Ketogenic Diet Acts on Body Remodeling and MicroRNAs Expression Profile","volume":"8","author":"Cannataro","year":"2019","journal-title":"MicroRNA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamadermatol.2018.1412","article-title":"Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review","volume":"154","author":"Ford","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Cannataro, R., Di Maio, L., Malorgio, A., Levi Micheli, M., and Cione, E. (2021). Spondyloarthritis and Strength Training: A 4-Year Report. J. Funct. Morphol. Kinesiol., 6.","DOI":"10.3390\/jfmk6030058"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/4\/893\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:53:11Z","timestamp":1760136791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/4\/893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["biomedicines10040893"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10040893","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]}}}